Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma

Thanos P. Mourikis(Cancer Research UK), Shaun R. Preston(Royal Surrey County Hospital), Vijayendran Sujendran, Jan Bornschein(John Radcliffe Hospital), Joel Nulsen(King's College London), Andy G. Lynch(University of St Andrews), Stephen J. Hayes(Salford Royal NHS Foundation Trust), Charles Crichton(University of Oxford), Andrew D Sharrocks(University of Manchester), Alex Northrop, Jason Crawte(University of Cambridge), Yeng Ang(The University of Texas MD Anderson Cancer Center), Annalise Katz‐Summercorn(University of Cambridge), Jim Davies(University of Oxford), Rachel de la Rue, Shalini Malhotra(Addenbrooke's Hospital), Lorena Benedetti(King's College London), Juliane Perner(University of Cambridge), Elwira Fidziukiewicz, Jesper Lagergren(Karolinska University Hospital), Rebecca C. Fitzgerald(Cancer Research UK), Sujath Abbas(University of Cambridge), Damjan Temelkovski(King's College London), Rachael Fels Elliott(University of Cambridge), Andrew Hindmarsh(Cambridge University Hospitals NHS Foundation Trust), Simon Tavaré(Ludwig Cancer Research), Paul A. Edwards(University of Cambridge), Paola Scaffidi(European Institute of Oncology), Michael Howell(The Francis Crick Institute), Elizabeth Foxall(King's College London), Gianmarco Contino(University of Cambridge), Lawrence Bower, Nicola Grehan, Matteo Cereda(MRC Laboratory of Molecular Biology), Ahmad Miremadi(Addenbrooke's Hospital), Sriganesh Jammula(European Institute of Oncology), Ginny Devonshire(University of Cambridge), Daniel Loureda(University of Cambridge), Barbara Nutzinger(University of Cambridge), Christopher Yau(Turing Institute), Shona MacRae(Hutchison/MRC Research Centre), Maria Secrier(University College London), Matthew Eldridge(University of Cambridge), Monika Tripathi(University of Cambridge), Ayesha Noorani, Peter Safranek, Maria O’Donovan(Addenbrooke's Hospital), Caitriona Hughes, Nick Carroll(Addenbrooke's Hospital), Xiaodun Li(AstraZeneca (Singapore))
Nature Communications
July 15, 2019
Cited by 49


Related Papers